Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
96
Frequently Asked Questions
What is Market Cap of Aduro Biotech Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Aduro Biotech Inc market cap is $271.1M.
What is the 52-week high for Aduro Biotech Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aduro Biotech Inc 52 week high is $20.20 as of September 09, 2025.
What is the 52-week low for Aduro Biotech Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aduro Biotech Inc 52 week low is $4.51 as of September 09, 2025.
What is Aduro Biotech Inc stock price today?
Aduro Biotech Inc stock price today is $16.39.
What was Aduro Biotech Inc stock price yesterday?
Aduro Biotech Inc stock price yesterday was $16.70.
What is the PE ratio of Aduro Biotech Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Aduro Biotech Inc’s P/E ratio is None.
What is the Price-to-Book ratio of Aduro Biotech Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Aduro Biotech Inc P/B ratio is 5.8078.
What is Aduro Biotech Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Aduro Biotech Inc's EBITDA is -0.82.
What is the 50-day moving average of Aduro Biotech Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Aduro Biotech Inc 50-day moving average is $13.49.